HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,810,737 | -51.3% | 205,815 | -56.7% | 2.02% | -50.7% |
| Q2 2023 | $48,885,634 | -45.3% | 475,310 | -42.0% | 4.09% | -34.4% |
| Q1 2023 | $89,399,193 | -26.2% | 819,124 | -23.0% | 6.23% | -41.2% |
| Q4 2022 | $121,133,955 | +54.2% | 1,064,446 | -16.2% | 10.61% | +55.8% |
| Q3 2022 | $78,574,987 | +10.7% | 1,269,591 | +42.7% | 6.81% | +35.0% |
| Q2 2022 | $70,953,140 | +10.6% | 889,583 | +45.8% | 5.04% | +2.4% |
| Q1 2022 | $64,171,682 | -34.1% | 609,939 | -32.5% | 4.93% | -20.8% |
| Q4 2021 | $97,388,100 | +26.2% | 903,750 | +28.3% | 6.22% | +16.1% |
| Q3 2021 | $77,189,552 | +11.9% | 704,670 | -4.4% | 5.36% | +16.5% |
| Q2 2021 | $68,988,146 | +7.8% | 736,738 | +5.9% | 4.60% | -4.4% |
| Q1 2021 | $64,010,046 | +64.8% | 695,459 | +31.0% | 4.81% | +5.6% |
| Q4 2020 | $38,840,894 | -17.7% | 530,976 | -12.6% | 4.56% | -56.6% |
| Q3 2020 | $47,210,564 | -11.0% | 607,757 | -36.3% | 10.49% | +44.2% |
| Q2 2020 | $53,064,338 | – | 954,738 | – | 7.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |